David W. End
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Retinoids in leukemia and cellular processes 5
- Protein Kinase Regulation and GTPase Signaling 3
- Oncology 6
- Cancer-related Molecular Pathways 5
- HER2/EGFR in Cancer Research 4
- Co-authors
- Gordon Guroff (5 shared papers)Geneva Dickens (2 shared papers)Judith E. Karp (2 shared papers)Jeffrey E. Lancet (2 shared papers)Scott H. Kaufmann (2 shared papers)Patrick Angibaud (5 shared papers)Marc Venet (5 shared papers)Constantine Londos (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Neurochemistry (2 papers)Molecular Cancer Therapeutics (1 paper)European Journal of Medicinal Chemistry (1 paper)Blood (1 paper)
- Partner nations
- United StatesCameroonHungary
In The Last Decade
David W. End
26 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 80
- Hematology 286
- Genetics 120
- Physiology 53
- Oncology 256
- Molecular Biology 635
Countries citing papers authored by David W. End
This map shows the geographic impact of David W. End's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. End with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. End more than expected).
Fields of papers citing papers by David W. End
This network shows the impact of papers produced by David W. End. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. End. The network helps show where David W. End may publish in the future.
Co-authors
The 25 scholars most cited alongside David W. End, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 390 | |
| 2 | 2006 | 115 | |
| 3 | 2001 | 95 | |
| 4 | 1981 | 92 | |
| 5 | 1999 | 86 | |
| 6 | 2003 | 62 | |
| 7 | 1981 | 54 | |
| 8 | 1982 | 39 | |
| 9 | Chemoprevention of benzo(a)pyrene-induced lung tumors in mice by the farnesyltransferase inhibitor R115777. | 2003 | 32 |
| 10 | 2010 | 30 | |
| 11 | 2003 | 28 | |
| 12 | 1979 | 27 | |
| 13 | 2003 | 24 | |
| 14 | 1981 | 21 | |
| 15 | 1983 | 16 | |
| 16 | 2003 | 15 | |
| 17 | 2006 | 14 | |
| 18 | A comparative study of the disposition of (-)-delta 9-tetrahydrocannabinol in neuroblastoma and glioma cells in tissue culture: relation cellular impairment. | 1977 | 12 |
| 19 | 2011 | 11 | |
| 20 | 2006 | 10 |
About David W. End
David W. End is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Cellular and Molecular Neuroscience and Neurology, having authored 26 papers that have together received 1.2k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (5 papers), Cancer-related Molecular Pathways (5 papers), HER2/EGFR in Cancer Research (4 papers), Click Chemistry and Applications (3 papers), Neuroscience and Neuropharmacology Research (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Estrogen and related hormone effects (3 papers) and Quinazolinone synthesis and applications (2 papers). The work is most often cited by research in Hematology (286 citations), Genetics (120 citations), Physiology (53 citations), Oncology (256 citations) and Molecular Biology (635 citations). David W. End has collaborated with scholars based in United States, Cameroon and Hungary. Frequent co-authors include Gordon Guroff, Geneva Dickens, Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann, Patrick Angibaud, Marc Venet, Constantine Londos, Michael L. Tidwell and Alain Thibault. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Neurochemistry, Molecular Cancer Therapeutics, European Journal of Medicinal Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.